The Biopreservation Market is to Touch $9.3 Billion by 2030; The increasing demand for shelf-stable food products and enhanced preservation techniques in industries like food & beverages, pharmaceuticals, and healthcare are major drivers for the mark

The Biopreservation Market size is estimated to reach $9.3 billion by 2030, growing at a CAGR of 19.4% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Biopreservation Market  – By Product {Equipment [Freezers, Refrigerators, Consumables (Vials, Straws, Microtiter plates, Bags and Liquid Nitrogen (LN2) tanks)], Media [Pre-formulated media, Home-brew media], Laboratory Information Management System (LIMS)}, By Cell Providers (CD34+, by Volume (Number of Units), CD19+, by Volume (Number of Units), MSC, by Volume (Number of Units), iPSC, by Volume (Number of Units), hESC, by Volume (Number of Units), Tumor cells, by Volume (Number of Units)), By Biospecimen (Human Tissue Samples, Organs, Stem Cell and Others), By Application[Regenerative Medicine (Cell therapy and Gene therapy), Biobanking (Human eggs, Human sperm, Veterinary IVF and Drug discovery) By End User (Biobanks, Gene Banks, Hospitals and Others), By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030”.

The biopreservation market, which focuses on employing controlled or natural microbial agents to increase product safety and shelf life, is a quickly expanding segment of the larger life sciences and biotechnology business. Utilizing bioactive compounds like organic acids, peptides, and bacteriocins or beneficial microorganisms like probiotics, biopreservation aims to stop the growth of infections or spoiling microorganisms. Key factors propelling the market include the growing need for shelf-stable food goods and improved preservation methods in sectors like food and beverage, pharmaceuticals, and healthcare. Biopreservation techniques have also become more popular due to increased demand for natural preservation solutions and increased awareness of food safety. Additionally, consumers are becoming more interested in clean-label items that don't include artificial preservatives.

North America dominated the Biopreservation Market in 2023 with a market share of 44%. In 2023, North America dominated the biopreservation market due to a number of important aspects that contribute to its dominance in the industry. With large investments in biotechnology and medical research, the area boasts a strong healthcare system. Adoption of biopreservation technologies is facilitated by this infrastructure, which is crucial for fields like regenerative medicine, clinical trials, and drug development. With the support of significant biotechnology and pharmaceutical firms, as well as public and private research institutes, the United States leads the world in biopreservation innovation. Furthermore, biobanks—which preserve biological samples for upcoming medical research—as well as the need for stem cell therapies, tissue regeneration, and customized medicine have all grown significantly in North America.

The market for biopreservation has been significantly influenced by the growing need for stem cell research and regenerative medicine. The discipline of regenerative medicine, which uses stem cells to replace or repair damaged tissues and organs, is expanding quickly. Because stem cells can develop into numerous types of cells that can restore tissues or organs, they are an essential part of this research. These stem cells and other biological materials are difficult to store and preserve, necessitating sophisticated biopreservation methods to keep them viable for use in the future. Research on stem cells is essential for treating a variety of illnesses, including neurological problems, diabetes, heart disease, and spinal cord injuries. The necessity for trustworthy biopreservation techniques to store these biological components grows as the need for efficient regenerative treatments rises. Because successful therapeutic outcomes depend on the ability to preserve stem cells, tissues, and organs for later use, the market for biopreservation is expanding due to the rise in regenerative medicine applications.

The biopreservation business is expanding thanks in large part to developments in tissue preservation and biobanking technology. Blood, tissues, and DNA are among the biological materials kept in biobanks for use in research, medication development, and illness prevention. The capacity to maintain the integrity of the samples over time is essential to the success of these biobanks. Long-term storage of biological materials without sacrificing their quality is now possible thanks to the development of more effective and efficient biopreservation methods including vitrification and cryopreservation. Significant scientific advancements in tissue preservation have occurred recently, including the application of innovative cryoprotectants and improved freezing procedures.